Fenbendazole is a broad-spectrum anthelmintic medication primarily used in veterinary medicine to treat animal gastrointestinal parasites. It belongs to the benzimidazole class of medications and is effective against various parasites, including roundworms, hookworms, whipworms, and certain animal tapeworms.
Although there’s limited research specifically focused on fenbendazole for pancreatic cancer, several studies have explored its anticancer properties in general. But the research is still in its early stages, and more research, including clinical trials, is needed to determine its success and safety in people with pancreatic cancer.
Fenbendazole for Pancreatic Cancer: What Research Shows